U.S. flag

An official website of the United States government

NM_000169.3(GLA):c.181G>C (p.Asp61His) AND Fabry disease

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 27, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003239279.2

Allele description [Variation Report for NM_000169.3(GLA):c.181G>C (p.Asp61His)]

NM_000169.3(GLA):c.181G>C (p.Asp61His)

Genes:
RPL36A-HNRNPH2:RPL36A-HNRNPH2 readthrough [Gene - HGNC]
GLA:galactosidase alpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_000169.3(GLA):c.181G>C (p.Asp61His)
HGVS:
  • NC_000023.11:g.101407723C>G
  • NG_007119.1:g.5241G>C
  • NG_016327.1:g.4521C>G
  • NM_000169.3:c.181G>CMANE SELECT
  • NM_001199973.2:c.301-4213C>G
  • NM_001199974.2:c.178-4213C>G
  • NM_001406747.1:c.181G>C
  • NM_001406748.1:c.181G>C
  • NM_001406749.1:c.181G>C
  • NP_000160.1:p.Asp61His
  • NP_000160.1:p.Asp61His
  • NP_001393676.1:p.Asp61His
  • NP_001393677.1:p.Asp61His
  • NP_001393678.1:p.Asp61His
  • LRG_672t1:c.181G>C
  • LRG_672:g.5241G>C
  • LRG_672p1:p.Asp61His
  • NC_000023.10:g.100662711C>G
  • NM_000169.2:c.181G>C
  • NR_164783.1:n.203G>C
  • NR_176252.1:n.203G>C
  • NR_176253.1:n.203G>C
Protein change:
D61H
Molecular consequence:
  • NM_001199973.2:c.301-4213C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001199974.2:c.178-4213C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000169.3:c.181G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406747.1:c.181G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406748.1:c.181G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406749.1:c.181G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_164783.1:n.203G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_176252.1:n.203G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_176253.1:n.203G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Fabry disease
Synonyms:
Angiokeratoma, diffuse; Anderson-Fabry disease; Hereditary dystopic lipidosis; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010526; MedGen: C0002986; Orphanet: 324; OMIM: 301500; Human Phenotype Ontology: HP:0001071

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0039352943billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jun 27, 2023)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From 3billion, SCV003935294.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)

Description

The missense variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest the damaging effect of the variant on the gene or gene product (REVEL: 0.44; 3Cnet: 0.93). As the evidence of pathogenicity is insufficient at this time, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024